Skip to main content
. 2020 Nov 3;50(7):1679–1690. doi: 10.3906/sag-2005-327

Table 2.

The main immunological targets in the treatment of cancer gene therapy.

Tumor cells
Immunuostimulatory cytokines (GM-CSF, IL-12, CD40L, IL-12)
T-cells
NK cells
Suicide genes (Cytosine deaminase, Thymidine kinase)
Oncolytic vectors